|
Volumn 102, Issue 3A, 1997, Pages 61-70
|
Prevention and treatment of respiratory syncytial virus and parainfluenza viruses in immunocompromised patients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA INTERFERON;
IMMUNOGLOBULIN;
IMMUNOMODULATING AGENT;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY HNK 20;
MONOCLONAL ANTIBODY RSHZ 19;
MONOCLONAL ANTIBODY SB 209763;
POLYCLONAL ANTIBODY;
RESPIRATORY SYNCYTIAL PNEUMOVIRUS IMMUNOGLOBULIN;
RESPIRATORY SYNCYTIAL VIRUS ANTIBODY;
RESPIRATORY SYNCYTIAL VIRUS VACCINE;
RIBAVIRIN;
UNCLASSIFIED DRUG;
VIRUS VACCINE;
ACTIVE IMMUNIZATION;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG MEGADOSE;
HUMAN;
IMMUNE DEFICIENCY;
INHALATIONAL DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
PARAINFLUENZA VIRUS;
PASSIVE IMMUNIZATION;
PRIORITY JOURNAL;
RESPIRATORY SYNCYTIAL PNEUMOVIRUS;
RESPIRATORY TRACT INFECTION;
VIRUS INFECTION;
VIRUS PNEUMONIA;
ADULT;
ANTI-INFLAMMATORY AGENTS;
ANTIBODIES, MONOCLONAL;
ANTIVIRAL AGENTS;
BRONCHODILATOR AGENTS;
CHILD;
DIAGNOSIS, DIFFERENTIAL;
DRUG THERAPY, COMBINATION;
HUMANS;
IMMUNOCOMPROMISED HOST;
INFLUENZA VACCINES;
ORTHOMYXOVIRIDAE;
ORTHOMYXOVIRIDAE INFECTIONS;
RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;
STEROIDS;
|
EID: 0030980218
PISSN: 00029343
EISSN: None
Source Type: Journal
DOI: 10.1016/s0002-9343(97)00014-4 Document Type: Article |
Times cited : (76)
|
References (2)
|